Mucositis, also referred to as mucosal barrier injury, is one of the most debilitating side
effects of radiotherapy and chemotherapy treatment. Clinically, mucositis is associated with …

Chemotherapy-induced intestinal mucositis, a painful debilitating condition affecting up to 40–
100% of patients undergoing chemotherapy, can reduce the patients' quality of life, add …

Cancer patients receiving chemotherapy often develop mucositis as a direct result of their
treatment. Recently, the intestinal microbiota has attracted significant attention in the …

Background Gastrointestinal mucositis is defined as inflammation and/or ulcers of the
gastrointestinal tract occurring as a complication of chemotherapy and radiation therapy …

Purpose Earlier, we showed in acute myeloid leukemia (AML) patients that the microbiota
changes dramatically during anticancer treatment, coinciding with gastrointestinal mucositis …

Introduction: Radiotherapy is a mainstay of solid tumor management but can be associated
with unacceptable levels of off-target tissue toxicity which impact treatment outcomes and …

During the last 20 years, a new field of research delineating the importance of the microbiota
in health and diseases has emerged. Inappropriate host-microbiota interactions have been …

Intestinal mucositis remains one of the most debilitating side effects related to
chemotherapy. The onset and persistence of mucositis is an intricate physiological process …

Inflammatory bowel disease (IBD) is a multifactorial disease which arises as a result of the
interaction of genetic, environmental, barrier and microbial factors leading to chronic …

The intestinal mucosal barrier, which is composed of epithelial cells and mucus layers
secreted by goblet cells and contains commensal bacteria, constitutes the first line of …